Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains
Frédéric Le Gal, Ségolène Brichler, Tudor Drugan, et al.
Hepatology (2017) Vol. 66, Iss. 6, pp. 1826-1841
Closed Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
Haiyan Chen, Danting Shen, Dong‐Ze Ji, et al.
Gut (2018) Vol. 68, Iss. 3, pp. 512-521
Closed Access | Times Cited: 335
Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Stephan Urban, Christoph Neumann‐Haefelin, Pietro Lampertico
Gut (2021) Vol. 70, Iss. 9, pp. 1782-1794
Open Access | Times Cited: 176
Hepatitis D Virus Infection
Tarik Asselah, Mario Rizzetto
New England Journal of Medicine (2023) Vol. 389, Iss. 1, pp. 58-70
Closed Access | Times Cited: 55
The evolution and clinical impact of hepatitis B virus genome diversity
Peter Revill, Thomas Tu, Hans Netter, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 10, pp. 618-634
Closed Access | Times Cited: 136
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta
Dominique Roulot, Ségolène Brichler, Richard Layese, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1046-1062
Open Access | Times Cited: 117
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
Cihan Yurdaydın, Zaigham Abbas, Marı́a Buti, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 5, pp. 1008-1015
Open Access | Times Cited: 100
Pathogenesis of and New Therapies for Hepatitis D
Christopher Koh, Theo Heller, Jeffrey S. Glenn
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 461-476.e1
Open Access | Times Cited: 98
S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11)
Markus Cornberg, Lisa Sandmann, Ulrike Protzer, et al.
Zeitschrift für Gastroenterologie (2021) Vol. 59, Iss. 07, pp. 691-776
Open Access | Times Cited: 73
Hepatitis Delta Virus and Hepatocellular Carcinoma
Daniele Lombardo, Maria Stella Franzè, Giuseppe Caminiti, et al.
Pathogens (2024) Vol. 13, Iss. 5, pp. 362-362
Open Access | Times Cited: 10
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
Marc Puigvehí, Carlos Moctezuma‐Velázquez, Augusto Villanueva, et al.
JHEP Reports (2019) Vol. 1, Iss. 2, pp. 120-130
Open Access | Times Cited: 66
Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta
A. Wranke, Svenja Hardtke, Benjamin Heidrich, et al.
Journal of Viral Hepatitis (2020) Vol. 27, Iss. 12, pp. 1359-1368
Open Access | Times Cited: 60
Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates
Wenshi Wang, Florian A. Lempp, Franziska Schlund, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 311-323
Open Access | Times Cited: 43
A Review of HDV Infection
Gian Paolo Caviglia, Alessia Ciancio, Mario Rizzetto
Viruses (2022) Vol. 14, Iss. 8, pp. 1749-1749
Open Access | Times Cited: 36
HDV RNA assays: Performance characteristics, clinical utility, and challenges
Heiner Wedemeyer, Mitchell Leus, Thomas R. Battersby, et al.
Hepatology (2023)
Open Access | Times Cited: 19
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
Julius Hollnberger, Yang Liu, Simin Xu, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 657-665
Closed Access | Times Cited: 18
ADAR Editing in Viruses: An Evolutionary Force to Reckon with
Helen Piontkivska, Benjamin Wales-McGrath, Michael M. Miyamoto, et al.
Genome Biology and Evolution (2021) Vol. 13, Iss. 11
Open Access | Times Cited: 39
Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real‐life
Tarik Asselah, Dimitri Loureiro, Frédéric Le Gal, et al.
Liver International (2021) Vol. 41, Iss. 7, pp. 1509-1517
Closed Access | Times Cited: 37
Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin
Hans Netter, Marilou Barrios, Margaret Littlejohn, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 37
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression
Mathias Jachs, Marlene Panzer, Lukas Hartl, et al.
JHEP Reports (2023) Vol. 5, Iss. 8, pp. 100751-100751
Open Access | Times Cited: 16
Different evolutionary dynamics of hepatitis B virus genotypes A and D, and hepatitis D virus genotypes 1 and 2 in an endemic area of Yakutia, Russia
А. А. Карлсен, K. K. Kyuregyan, О. В. Исаева, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Hepatitis Delta Infection: A Clinical Review
Brian L. Pearlman
Seminars in Liver Disease (2023) Vol. 43, Iss. 03, pp. 293-304
Open Access | Times Cited: 11
The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide Study
Ifeorah Ijeoma, Athénaïs Gerber, Samira Dziri, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1236-1236
Open Access | Times Cited: 4
Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection
Jiayi Zhou, Hannah Kaiser, Eduardo Melani Rocha, et al.
JHEP Reports (2025), pp. 101400-101400
Open Access
Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis
Lin-Yuan Chen, Xiao‐Yu Pang, Hemant Goyal, et al.
Gut Pathogens (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada
Carla Osiowy, Ken Swidinsky, Sarah Haylock‐Jacobs, et al.
JHEP Reports (2022) Vol. 4, Iss. 5, pp. 100461-100461
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top